PODCAST

Industry Feature

ReachMD

science & medicine medicine

All Episodes

00:00:00

The Pathophysiology and Pathoetiology of Heart Failure

Industry Feature ·

2023/11/10

Guest: Stephen Greene, MD One of the most important things we know about heart failure is that it doesn’t affect everyone equally, especially when you consider heart failure with reduced ejection fraction versus preserved ejection fraction. Dive into the complex pathophysiology and pathoetiology surrounding heart failure and how it differs when ejection fraction is reduced versus when it’s preserved with Dr. Stephen Greene, an advanced heart failure specialist at Duke Heart Transplant

00:00:00

Guideline Directed Medical Therapy for the Management...

Industry Feature ·

2023/11/10

Guest: Stephen Greene, MD In 2022, the American Heart Association, American College of Cardiology, and Heart Failure Society of America created a joint guideline for the management of heart failure. Explore what the recommendations say and how they can help improve patient outcomes with Dr. Stephen Greene, an advanced heart failure specialist at Duke Heart Transplant Clinic and a cardiologist at Duke Cardiology Clinic in Durham, North Carolina. Sponsored by Boehringer Ingelheim

00:00:00

The Disease Burden and Epidemiology of Heart Failure

Industry Feature ·

2023/11/10

Guest: Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN Approximately 6.2 million adults in the US have heart failure (hf), and this number is projected to grow to more than 8 million by 2030. Knowing this alarming statistic, what do we need to know about the clinical characteristics of hf? Take a deep dive with Dr. Nancy Albert, associate chief nursing officer for the Office of Nursing Research and Innovation. Sponsored by Boehringer Ingelheim

00:00:00

Heart Failure Disease State Awareness

Industry Feature ·

2023/11/10

Guest: Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN There are 4 stages of heart failure, ranging from being at risk for heart failure to having an advanced condition. So what key insights should we know about the ACC/AHA stages of heart failure and the NYHA heart failure functional classifications? Discover more with Dr. Nancy Albert, associate chief nursing officer for the Office of Nursing Research and Innovation. Sponsored by Boehringer Ingelheim

00:00:00

The Importance of Making an Accurate and Timely Heart...

Industry Feature ·

2023/11/10

Guest: Pamela Kushner, MD, FAAFP Clinicians may agree that several challenges exist in diagnosing heart failure because patients may present with nonspecific symptoms or may have comorbidities. So what factors are important to evaluate when detecting and diagnosing heart failure in patients? Join Dr. Pam Kushner, clinical professor at the University of California at Irvine, as she walks us through the answer to this and more. Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc

00:00:00

A Treatment for NYHA Class II-III Obstructive HCM...

Industry Feature ·

2023/11/07

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Amy Sehnert, MD With the FDA’s approval of CAMZYOS® (mavacamten), the first and only cardiac myosin inhibitor for symptomatic New York Heart Association (NYHA) class II-III adult patients, healthcare professionals and patients now have another treatment option that targets HCM at the source. Learn more about the clinical trial data that supported the FDA approval, and how healthcare professionals can prescribe CAMZYOS from Dr. Amy

00:00:00

Integrating Multicancer Early Detection into Clinical...

Industry Feature ·

2023/10/24

Host: Sana Raoof, MD, PhD Guest: Candace T. Westgate, DO, MPH, FACOG Guest: Mylynda Massart, MD, PhD The last five years have seen exciting progress with liquid biopsy tests, with one of them being a screening tool for multi-cancer early detection that looks for methylation patterns that can detect more cancers earlier, even before symptoms appear.1,2 Learn how you can incorporate this screening tool into clinical practice with Drs. Sana Raoof, Candace Westgate, and Mylynda

00:00:00

Cancer Screenings: The Impacts of Early Detection...

Industry Feature ·

2023/10/24

Host: Jennifer Caudle, DO Guest: Sana Raoof, MD, PhD There’s a multi-cancer early detection test available that uses a targeted methylation, next-generation sequencing-based assay to detect and analyze cell-free DNA in the bloodstream, deploy machine learning to detect a cancer signal, and predict the likely origin of the signal.2 Explore the science behind this advancement that provides the highest specificity of any cancer screening tool1 with Dr. Jennifer Caudle and Dr. Sana

00:00:00

Addressing Hesitancy on Biosimilars: From Development...

Industry Feature ·

2023/09/14

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jerome Goldschmidt, MD Despite the potential benefits of biosimilars, such as decreased costs for patients, healthcare systems, and payers,1,2 their uptake in U.S. clinical practice has lagged behind that of the E.U.2 That’s why Dr. Jerome Goldschmidt joins Dr. Charles Turck to address common misconceptions surrounding biosimilars and examine key points in their development, manufacturing, and approval process. Dr. Goldschmidt is a

00:00:00

From Monoamines to Neurocircuits: Our Evolving...

Industry Feature ·

2023/08/30

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joseph F. Goldberg, MD Our understanding of depression has evolved over the past several decades, leading us to some potential new treatment options that focus on neuroplasticity. Learn more about the history of depression treatment approaches and the emerging concept of neuroplasticity with Dr. Charles Turck and Dr. Joseph Goldberg, Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai in New York City

00:00:00

From Heterogeneity Comes New Insights: Exploring the...

Industry Feature ·

2023/08/29

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jonathan Silverberg, MD, PhD, MPH Atopic dermatitis is more than a disease of the skin. It’s a complex and heterogeneous inflammatory disease mediated by multiple T-cell–driven inflammatory pathways, like the OX40 pathway, leading to chronic and persistent symptoms and significant burden.1-4 Explore the heterogeneity of atopic dermatitis and the importance of OX40 signaling in disease pathogenesis with Dr Charles Turck and Dr

00:00:00

Enhancing Your Aesthetic Skillset: A New Training and...

Industry Feature ·

2023/07/07

Host: Jennifer Caudle, DO Guest: Jeran Wadlow Guest: Josh Elmassian, MBA Allergan Medical Institute® has taken a personalized approach to training HCPs in medical aesthetics with the launch of AMI Online. Discover multiple online courses spanning the Allergan Aesthetics portfolio, including content on JUVÉDERM® VOLUX® XC. Experience how AMI Online’s evidence-based and progressive training curricula can educate and empower the aesthetics community. Join Dr Jennifer Caudle as she

00:00:00

Inherited Retinal Diseases, Genetic Testing, and What...

Industry Feature ·

2023/06/21

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Mark Pennesi, MD, PhD Approximately 165,700 people in the United States are affected by inherited retinal diseases (IRDs) and treatment options for these conditions are limited. So what role does genetic testing play in the patient journey of people living with IRDs? Join Dr. Charles Turck as he dives into this topic with Dr. Mark Pennesi, Professor of Ophthalmology and an IRD specialist affiliated with the Casey Eye Institute at the

00:00:00

Future Imaging Modalities in Spondyloarthritis

Industry Feature ·

2023/05/18

Host: Ethan Craig, MD, MHS Guest: Walter Maksymowych, MB ChB, FRCP(C), FACP Appealing treatment options for patients with SpA might be right around the corner. So why do we need further imaging modalities and what do they have to offer? To give us a peek into the future, Dr. Ethan Craig is joined by Dr. Maksymowych, Professor of Medicine at the University of Alberta and Chief Medical Officer of CARE Arthritis. Dr. Craig and Dr. Bakewell are Novartis Consultants. 269162 03/23

00:00:00

The Role of Imaging in Determining Treatment...

Industry Feature ·

2023/05/04

Host: Ethan Craig, MD, MHS Guest: Catherine J. Bakewell, MD Disease activity in patients with spondyloarthritis (SpA) may be challenging to assess. So when should ultrasound and MRI be used to support clinical assessment? To provide us with more insights into this topic, Dr. Ethan Craig is joined by Dr. Catherine Bakewell, Rheumatologist at Intermountain Healthcare in Salt Lake City, Utah. Dr. Craig and Dr. Bakewell are Novartis Consultants. 269162 03/23

00:00:00

A Changing Paradigm for Cancer Screening: Exploring...

Industry Feature ·

2023/04/24

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Eric Klein, MD Cancer remains the second-leading cause of death in the U.S., creating an urgent need to detect cancer at earlier stages when outcomes are better. With the emergence of novel multi-cancer screening technologies, the potential public health impact may be substantial. Given these advances, is it time to rethink the way clinical trials are designed to assess the effectiveness of these screening technologies? Joining Dr

00:00:00

Using MRI to Differentiate Axial Spondyloarthritis...

Industry Feature ·

2023/04/20

Host: Ethan Craig, MD, MHS Guest: Walter Maksymowych, MB ChB, FRCP(C), FACP Over the last 20 year or so, magnetic resonance imaging (MRI) has changed how we evaluate axial spondyloarthritis (axSpA). But with a concerning rate of false-positive MRIs in recent data, it’s time to review where the field stands now, and update what the role of MRI seems to be in the diagnosis of spondyloarthritis (SpA). Join Dr. Ethan Craig in this discussion with an expert in SpA imaging, Dr

00:00:00

Differentiating Peripheral Spondyloarthritis from...

Industry Feature ·

2023/04/06

Host: Ethan Craig, MD, MHS Guest: Catherine J. Bakewell, MD Diagnosing patients with peripheral spondyloarthritis (pSpA) can often be challenging, particularly when differentiating it from other causes of inflammatory and non-inflammatory arthritis. So what is the role of ultrasound when diagnosing pSpA in patients? Join Dr. Ethan Craig as he guides this discussion with Dr. Catherine Bakewell, Rheumatologist at Intermountain Healthcare in Salt Lake City, Utah. Dr. Craig and Dr

00:00:00

The Future of Multiple Sclerosis Patient Care:...

Industry Feature ·

2023/04/03

Guest: Shibeshih Belachew, MD PhD Host: Charles Turck, PharmD, BCPS, BCCCP Technology is advancing exponentially, and this has been more evident than ever in the field of medicine. In fact, biotech and pharmaceutical companies are bringing biology and technology together to better meet patient needs across a range of specialties. So what are the latest research and initiatives in digital health that are working towards a future of more personalized medicine for patients with

00:00:00

Understanding Biosimilars: What's Driving Adoption &...

Industry Feature ·

2023/03/30

Host: Jennifer Caudle, DO Guest: Stefanie Cribb, PharmD Guest: Ryan Haumschild, PharmD Guest: Jennifer Rubin Guest: Ira Steinberg, MD There’s been a lot of focus recently on biosimilars and their potential role in evolving the healthcare system. We're digging in deeper to understand what makes biosimilars so exciting. Joining Dr. Jennifer Caudle to discuss the biosimilar approval process and the important commitment supporting healthcare providers and patients in their

47 results

Industry Feature

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事